Antibiotic sales soared during India’s first surge of COVID-19, suggesting that the drugs were inappropriately used to treat mild and moderate COVID-19 infections, according to new research. The excessive usage is especially concerning because antibiotic overuse increases the risk for drug-resistant infections — not just in India, but worldwide.